Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Getting diagnosed with a serious condition can cause a sense of loss. A psychotherapist – and fellow primary immune deficienc…
CSL supplies critical antivenom treatments that can save the life of someone bitten by a Sydney Funnel-web Spider. Find out h…
CSL recently attended an international symposium about Patient Blood Management organized by NATA, the Network for the Advanc…
CSL, which develops and manufactures medicines and vaccines, welcomed children and families to its locations in Australia, Ge…
If someone has a weakened immune system, they’re more vulnerable to infection and may need to take extra precautions to prote…
For patients who have symptoms and no diagnosis, it may take years to get an answer. EURORDIS hosted a webinar about “the dia…
At the event for industry leaders, President Emmanuel Macron positioned France as a global innovator ready to partner with co…
A rare condition, HAE, causes unpredictable swelling attacks that can be life-threatening. Day-to-day, patients live with the…
The organization founded by Philadelphia’s Dr. David Fajgenbaum recently received a big funding boost from a U.S. health agen…
Americas
Asia Pacific
Middle East
Europe
